Primary Esrd Modality In New Esrd Patients, 1995-97
This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA
Overview
Download & View Primary Esrd Modality In New Esrd Patients, 1995-97 as PDF for free.
More details
- Words: 1,040
- Pages: 18
Primary ESRD Modality in New ESRD Patients, 1995-97* 100
New Patients (%) 84.3
80 60 40 20
8.7
0 Hemo
CAPD
3.1
0.2
CCPD
IPD
*Reported on HCFA Medical Evidence Form
3.7
Transplant
IV -1 USRDS 1999
Demographic Characteristics of New ESRD Patients, 1997* 80 60
New Patients (Age or %) 61.1 53.1 44.4
40 20 0
Average Age *Reported on HCFA Medical Evidence Form **Primary/contributing cause of ESRD
% Male
% Diabetes** IV -2 USRDS 1999
Reported Race and Hispanic Ethnicity among New ESRD Patients, 1997* 80
New Patients (%) 3000
63.5
60
Hispanic = 10.9% overall
Counts of races included in "Other" category
2000 1000
40 28.7
Number of People 2189
515 182
0
20 2.9
0
1.1
3.8
Middle East
White
Black
Asian / Pacific Islander
*Reported on HCFA Medical Evidence Form Unknown race is not included in percentages. Approximately 0.6% of patients reported race as “Unknown”.
Indian Subcontinent
Native American / Alaskan Native
Other/ Multicultural
Other IV -3 USRDS 1999
Primary Detailed Disease Groups Reported among New ESRD Patients, 1997* 60
New Patients (%) 44.4
40 26.6
20 9.9 2.3
3.9
7.6 3.3
2.0
0
Diabetes
Hypertension
Glomerulo- Secondary Interstitial Cystic/ Neoplasms/ nephritis GN/ Vascu- Nephritis Hereditary/ Tumors litis PyeloCongenital Nephritis *Reported on HCFA Medical Evidence Form
Miscellaneous IV - 4 USRDS 1999
Primary Disease Reported among New ESRD Patients by Year, 1995-97* 50 40 30
New Patients (%) 42.3
43.3
44.4
1995
25.8 26.0
1996
1997
26.6
20
17.9 17.316.8 11.310.8
10
9.9 2.7 2.5 2.4
0
Diabetes
Hypertension
*Reported on HCFA Medical Evidence Form
Glomerulonephritis
Cystic Kidney Disease
Other Causes IV -5 USRDS 1999
Cardiovascular Patient Characteristics among New Dialysis Patients, 1997* 40 30
New Patients (%) 34.7
25.1
20
15.6 9.7
9.4
10
0.9
0
Congestive Heart Failure
CAD
*Reported on HCFA Medical Evidence Form
MI
Cardiac Arrest
CVD / CVA/ TIA
Peripheral Vascular Disease IV -6 USRDS 1999
40
Ischemic Heart Disease (CAD) and Myocardial Infarction (MI) by Gender and Diabetes in New Dialysis Patients, 1997* New Patients (%)
CAD
30
MI
29.5
27.0 22.9
21.5
20 10
10.6
10.7
8.1
8.4
0
Male
Gender
Female
*Reported on HCFA Medical Evidence Form
Yes
Diabetes
No IV -7 USRDS 1999
Ischemic Heart Disease (CAD) and Myocardial Infarction (MI) by Age for New Dialysis Patients, 1997* 40
New Patients (%) CAD
MI
35.6 32.8
30 20.6
20
12.8
12.2
10
8.1 4.6
2.0
0
20-44
45-64
*Reported on HCFA Medical Evidence Form
Age
65-74
75+ IV -8 USRDS 1999
Ischemic Heart Disease (CAD) and Myocardial Infarction (MI) by Race and Hispanic Ethnicity in New Dialysis Patients, 1997* 35 30
New Patients (%)
30.6
CAD
25.7
25
22.0
20 15
20.2
19.5
17.6 14.8 11.8
9.8
9.3
10 5
MI
5.1
5.6
5.9
6.0
0
White
Black
Asian
Native Other American
*Reported on HCFA Medical Evidence Form
Hispanic
NonHispanic
IV -9 USRDS 1999
Non-Cardiovascular Patient Characteristics among New Dialysis Patients, 1997* 30
New Patients (%) 24.1
20
10
7.4
5.2
5.5
4.6 1.7
0
Diabetes on insulin
COPD
Cancer
*Reported on HCFA Medical Evidence Form
Smoker
Inability to
Inability to
Ambulate
Transfer IV -10 USRDS 1999
Serum Albumin and Body Mass Index (BMI) for New ESRD Patients, 1995-98* 3.5
27 Average
Average Serum Albumin (g/dl)
3.4 3.3
26.05 3.25
3.22
3.2
25.39 3.20
25.52
25.67
BMI (kg/m2)
26
3.19
25
3.1 3.0
24
1995
1996
1997
1998
1995
1996
*Reported on HCFA Medical Evidence Form; 1998 data are through June
1997
1998
IV -11 USRDS 1999
Distribution of Facilities by Average Number of Comorbidities Reported per Patient, 1995-97* 60
Facilities (%)55.6 N = 3,250 Facilities**
50 40 31.5
30 20 8.8
10 0
3.5
0.2
0
0.3
0.1
<1 1 to <2 2 to <3 3 to <4 4 to <5 Average Number of Comorbidities Reported
*Reported on HCFA Medical Evidence Form **Excludes facilities with < 5 new patients in 3 years
5 to <6 IV -12 USRDS 1999
Distribution of Facilities by Percent of Patients with Zero Comorbidities Reported, 1995-97* 40
Facilities (%) 33.0
30
N = 3,250 Facilities**
27.2 18.7
20 10
7.3
5.7
2.8
1.9
0
0
0+ to 10%
10+ to 20%
20+ to 30%
30+ to 40%
40+ to 50%
50+ to 60%
1.5 60+ to 70%
0.4 70+ to 80%
0.7
0.6
80+ to 90+ to 90% < 100%
0.2 100%
Percent of Patients with Zero Comorbidities Reported *Reported on HCFA Medical Evidence Form **Excludes facilities with < 5 new patients in 3 years
IV -13 USRDS 1999
Serum Creatinine and GFR for New ESRD Patients by Age Group, 1995-97* 15
Average Serum Creatinine (mg/dl)
15 Average GFR (ml/min)**
10.8
10
8.7
7.5
7.0
6.6
7.1
7.7
8.0
10
5
5
0
0
20-44
45-64 65-74 Age
*Reported on HCFA Medical Evidence Form **MDRD Formula
75+
20-44 45-64
65-74 Age
75+ IV -14 USRDS 1999
Serum Creatinine and Weight for New ESRD Patients by Year, 1995-98* 10 9
80Average
Average Serum Creatinine (mg/dl) 8.7
71.3
71.8
8.5
73.0
70 8.1
8
72.1
Weight (kg)
8.0
60
7 6
50
1995
1996
1997
1998
1995 1996
*Reported on HCFA Medical Evidence Form; 1998 data are through June
1997
1998
IV -15 USRDS 1999
EPO Use Before ESRD by Age and Gender for New ESRD Patients, 1995-97* 40
Receiving EPO Before ESRD (%)
30 22.9
23.8
24.6
26.0
23.9
22.5
20 10 0
20-44
45-64
Age
65-74
*Reported on HCFA Medical Evidence Form
75+
Female
Male
Gender
IV -16 USRDS 1999
EPO Use Before ESRD for New ESRD Patients by Race and Hispanic Ethnicity, 1995-97* 40 30 20
Receiving EPO Before ESRD (%) 30.1 26.1 21.0
19.9
21.7
21.6
24.4
10 0
White
Black
Asian
Native Other American
*Reported on HCFA Medical Evidence Form
Hispanic
NonHispanic
IV -17 USRDS 1999
Prior vs. Current Employment among New ESRD Patients, Ages 20-64, 1997* 36
New Patients (%) 32
32
30 24
27
30
6 months before ESRD (missing = 10%)
27
At onset of ESRD (missing = 4%)
20
18 12 6
6 7
6 6
5 1
0
Employed** Unemployed Retired, Disabled
Retired by Age
1 0.5
Homemaker
*Reported on HCFA Medical Evidence Form. **Includes part-time and full-time. Patients with employment status missing are excluded.
Medical Leave
Student IV -18 USRDS 1999
New Patients (%) 84.3
80 60 40 20
8.7
0 Hemo
CAPD
3.1
0.2
CCPD
IPD
*Reported on HCFA Medical Evidence Form
3.7
Transplant
IV -1 USRDS 1999
Demographic Characteristics of New ESRD Patients, 1997* 80 60
New Patients (Age or %) 61.1 53.1 44.4
40 20 0
Average Age *Reported on HCFA Medical Evidence Form **Primary/contributing cause of ESRD
% Male
% Diabetes** IV -2 USRDS 1999
Reported Race and Hispanic Ethnicity among New ESRD Patients, 1997* 80
New Patients (%) 3000
63.5
60
Hispanic = 10.9% overall
Counts of races included in "Other" category
2000 1000
40 28.7
Number of People 2189
515 182
0
20 2.9
0
1.1
3.8
Middle East
White
Black
Asian / Pacific Islander
*Reported on HCFA Medical Evidence Form Unknown race is not included in percentages. Approximately 0.6% of patients reported race as “Unknown”.
Indian Subcontinent
Native American / Alaskan Native
Other/ Multicultural
Other IV -3 USRDS 1999
Primary Detailed Disease Groups Reported among New ESRD Patients, 1997* 60
New Patients (%) 44.4
40 26.6
20 9.9 2.3
3.9
7.6 3.3
2.0
0
Diabetes
Hypertension
Glomerulo- Secondary Interstitial Cystic/ Neoplasms/ nephritis GN/ Vascu- Nephritis Hereditary/ Tumors litis PyeloCongenital Nephritis *Reported on HCFA Medical Evidence Form
Miscellaneous IV - 4 USRDS 1999
Primary Disease Reported among New ESRD Patients by Year, 1995-97* 50 40 30
New Patients (%) 42.3
43.3
44.4
1995
25.8 26.0
1996
1997
26.6
20
17.9 17.316.8 11.310.8
10
9.9 2.7 2.5 2.4
0
Diabetes
Hypertension
*Reported on HCFA Medical Evidence Form
Glomerulonephritis
Cystic Kidney Disease
Other Causes IV -5 USRDS 1999
Cardiovascular Patient Characteristics among New Dialysis Patients, 1997* 40 30
New Patients (%) 34.7
25.1
20
15.6 9.7
9.4
10
0.9
0
Congestive Heart Failure
CAD
*Reported on HCFA Medical Evidence Form
MI
Cardiac Arrest
CVD / CVA/ TIA
Peripheral Vascular Disease IV -6 USRDS 1999
40
Ischemic Heart Disease (CAD) and Myocardial Infarction (MI) by Gender and Diabetes in New Dialysis Patients, 1997* New Patients (%)
CAD
30
MI
29.5
27.0 22.9
21.5
20 10
10.6
10.7
8.1
8.4
0
Male
Gender
Female
*Reported on HCFA Medical Evidence Form
Yes
Diabetes
No IV -7 USRDS 1999
Ischemic Heart Disease (CAD) and Myocardial Infarction (MI) by Age for New Dialysis Patients, 1997* 40
New Patients (%) CAD
MI
35.6 32.8
30 20.6
20
12.8
12.2
10
8.1 4.6
2.0
0
20-44
45-64
*Reported on HCFA Medical Evidence Form
Age
65-74
75+ IV -8 USRDS 1999
Ischemic Heart Disease (CAD) and Myocardial Infarction (MI) by Race and Hispanic Ethnicity in New Dialysis Patients, 1997* 35 30
New Patients (%)
30.6
CAD
25.7
25
22.0
20 15
20.2
19.5
17.6 14.8 11.8
9.8
9.3
10 5
MI
5.1
5.6
5.9
6.0
0
White
Black
Asian
Native Other American
*Reported on HCFA Medical Evidence Form
Hispanic
NonHispanic
IV -9 USRDS 1999
Non-Cardiovascular Patient Characteristics among New Dialysis Patients, 1997* 30
New Patients (%) 24.1
20
10
7.4
5.2
5.5
4.6 1.7
0
Diabetes on insulin
COPD
Cancer
*Reported on HCFA Medical Evidence Form
Smoker
Inability to
Inability to
Ambulate
Transfer IV -10 USRDS 1999
Serum Albumin and Body Mass Index (BMI) for New ESRD Patients, 1995-98* 3.5
27 Average
Average Serum Albumin (g/dl)
3.4 3.3
26.05 3.25
3.22
3.2
25.39 3.20
25.52
25.67
BMI (kg/m2)
26
3.19
25
3.1 3.0
24
1995
1996
1997
1998
1995
1996
*Reported on HCFA Medical Evidence Form; 1998 data are through June
1997
1998
IV -11 USRDS 1999
Distribution of Facilities by Average Number of Comorbidities Reported per Patient, 1995-97* 60
Facilities (%)55.6 N = 3,250 Facilities**
50 40 31.5
30 20 8.8
10 0
3.5
0.2
0
0.3
0.1
<1 1 to <2 2 to <3 3 to <4 4 to <5 Average Number of Comorbidities Reported
*Reported on HCFA Medical Evidence Form **Excludes facilities with < 5 new patients in 3 years
5 to <6 IV -12 USRDS 1999
Distribution of Facilities by Percent of Patients with Zero Comorbidities Reported, 1995-97* 40
Facilities (%) 33.0
30
N = 3,250 Facilities**
27.2 18.7
20 10
7.3
5.7
2.8
1.9
0
0
0+ to 10%
10+ to 20%
20+ to 30%
30+ to 40%
40+ to 50%
50+ to 60%
1.5 60+ to 70%
0.4 70+ to 80%
0.7
0.6
80+ to 90+ to 90% < 100%
0.2 100%
Percent of Patients with Zero Comorbidities Reported *Reported on HCFA Medical Evidence Form **Excludes facilities with < 5 new patients in 3 years
IV -13 USRDS 1999
Serum Creatinine and GFR for New ESRD Patients by Age Group, 1995-97* 15
Average Serum Creatinine (mg/dl)
15 Average GFR (ml/min)**
10.8
10
8.7
7.5
7.0
6.6
7.1
7.7
8.0
10
5
5
0
0
20-44
45-64 65-74 Age
*Reported on HCFA Medical Evidence Form **MDRD Formula
75+
20-44 45-64
65-74 Age
75+ IV -14 USRDS 1999
Serum Creatinine and Weight for New ESRD Patients by Year, 1995-98* 10 9
80Average
Average Serum Creatinine (mg/dl) 8.7
71.3
71.8
8.5
73.0
70 8.1
8
72.1
Weight (kg)
8.0
60
7 6
50
1995
1996
1997
1998
1995 1996
*Reported on HCFA Medical Evidence Form; 1998 data are through June
1997
1998
IV -15 USRDS 1999
EPO Use Before ESRD by Age and Gender for New ESRD Patients, 1995-97* 40
Receiving EPO Before ESRD (%)
30 22.9
23.8
24.6
26.0
23.9
22.5
20 10 0
20-44
45-64
Age
65-74
*Reported on HCFA Medical Evidence Form
75+
Female
Male
Gender
IV -16 USRDS 1999
EPO Use Before ESRD for New ESRD Patients by Race and Hispanic Ethnicity, 1995-97* 40 30 20
Receiving EPO Before ESRD (%) 30.1 26.1 21.0
19.9
21.7
21.6
24.4
10 0
White
Black
Asian
Native Other American
*Reported on HCFA Medical Evidence Form
Hispanic
NonHispanic
IV -17 USRDS 1999
Prior vs. Current Employment among New ESRD Patients, Ages 20-64, 1997* 36
New Patients (%) 32
32
30 24
27
30
6 months before ESRD (missing = 10%)
27
At onset of ESRD (missing = 4%)
20
18 12 6
6 7
6 6
5 1
0
Employed** Unemployed Retired, Disabled
Retired by Age
1 0.5
Homemaker
*Reported on HCFA Medical Evidence Form. **Includes part-time and full-time. Patients with employment status missing are excluded.
Medical Leave
Student IV -18 USRDS 1999
Related Documents
Esrd Pps Proposed Rule
June 2020 3
Antibiotic Dosing Esrd
November 2019 13
Dka He Esrd Ards Poisoning
June 2020 3
Modality
April 2020 15
Primary Key In Excel
November 2019 23More Documents from ""
Heather
June 2020 22
Ent Emergencies
June 2020 20
Sangita Dash, Md
June 2020 18
H. Pylori Stool Antigen Test
June 2020 16